- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
IMP.3: 21 residues within 4Å:- Chain A: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.4
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:S.73, A:R.327, A:S.334, A:D.369, A:D.369, A:G.371, A:G.392, A:S.393, A:S.393, A:S.393, A:Y.416, A:M.419, A:G.420, A:Q.446
IMP.7: 20 residues within 4Å:- Chain B: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, M.419, G.420, Q.446, G.447
- Ligands: NAD.8
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:S.73, B:R.327, B:S.334, B:I.337, B:D.369, B:D.369, B:G.371, B:G.392, B:S.393, B:S.393, B:S.393, B:Y.416, B:M.419, B:G.420, B:Q.446
IMP.11: 21 residues within 4Å:- Chain C: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.12
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:S.73, C:R.327, C:S.334, C:D.369, C:D.369, C:G.371, C:G.392, C:S.393, C:S.393, C:Y.416, C:M.419, C:G.420, C:Q.446
IMP.15: 21 residues within 4Å:- Chain D: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.16
15 PLIP interactions:15 interactions with chain D- Hydrogen bonds: D:S.73, D:R.327, D:S.334, D:D.369, D:D.369, D:G.370, D:G.371, D:G.392, D:S.393, D:S.393, D:S.393, D:Y.416, D:M.419, D:G.420, D:Q.446
IMP.19: 20 residues within 4Å:- Chain E: S.73, M.75, R.327, G.333, S.334, I.335, C.336, I.337, D.369, G.370, G.371, M.391, G.392, S.393, Y.416, M.419, G.420, Q.446, G.447
- Ligands: NAD.20
12 PLIP interactions:12 interactions with chain E- Hydrogen bonds: E:S.73, E:R.327, E:R.327, E:S.334, E:I.337, E:G.371, E:G.392, E:S.393, E:S.393, E:M.419, E:G.420, E:Q.446
IMP.23: 20 residues within 4Å:- Chain F: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, M.419, G.420, Q.446, G.447
- Ligands: NAD.24
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:S.73, F:S.73, F:R.327, F:S.334, F:D.369, F:G.371, F:G.392, F:S.393, F:M.419, F:G.420, F:Q.446
IMP.27: 22 residues within 4Å:- Chain G: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.28
12 PLIP interactions:12 interactions with chain G- Hydrogen bonds: G:S.73, G:S.73, G:N.308, G:R.327, G:S.334, G:D.369, G:G.371, G:G.392, G:S.393, G:M.419, G:G.420, G:Q.446
IMP.31: 20 residues within 4Å:- Chain H: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.32
11 PLIP interactions:11 interactions with chain H- Hydrogen bonds: H:S.73, H:S.73, H:R.327, H:S.334, H:D.369, H:G.371, H:G.392, H:S.393, H:M.419, H:G.420, H:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.4: 16 residues within 4Å:- Chain A: T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, T.338, M.419, G.420, Q.446
- Chain B: T.50, Q.474
- Ligands: IMP.3
12 PLIP interactions:10 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Q.446
- Hydrogen bonds: A:H.98, A:T.257, A:D.279, A:S.281, A:G.329, A:G.331, B:Q.474, B:Q.474
- pi-Stacking: A:H.258, A:F.287, A:F.287
NAD.8: 17 residues within 4Å:- Chain B: H.98, T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain C: T.50, Q.474
- Ligands: IMP.7
13 PLIP interactions:11 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:H.98, B:T.257, B:D.279, B:S.281, B:S.281, B:G.329, B:G.331, C:Q.474, C:Q.474
- Salt bridges: B:H.258
- pi-Stacking: B:F.287, B:F.287
- pi-Cation interactions: B:H.258
NAD.12: 17 residues within 4Å:- Chain C: H.98, T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, C.336, M.419, G.420, Q.446
- Chain D: T.50, Q.474
- Ligands: IMP.11
11 PLIP interactions:10 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:Q.446
- Hydrogen bonds: C:H.98, C:T.257, C:D.279, C:S.281, C:G.329, C:G.331, D:Q.474
- pi-Stacking: C:H.258, C:F.287, C:F.287
NAD.16: 17 residues within 4Å:- Chain A: T.50, Q.474
- Chain D: H.98, T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, C.336, M.419, G.420, Q.446
- Ligands: IMP.15
10 PLIP interactions:9 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:H.98, D:T.257, D:D.279, D:S.281, D:G.329, D:G.331, A:Q.474
- pi-Stacking: D:H.258, D:F.287, D:F.287
NAD.20: 16 residues within 4Å:- Chain E: H.98, T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain F: T.50, Q.474
- Ligands: IMP.19
13 PLIP interactions:1 interactions with chain F, 12 interactions with chain E- Hydrogen bonds: F:Q.474, E:H.98, E:T.257, E:T.257, E:D.279, E:S.281, E:G.329, E:G.331
- Hydrophobic interactions: E:Q.446
- Salt bridges: E:H.258
- pi-Stacking: E:H.258, E:F.287, E:F.287
NAD.24: 16 residues within 4Å:- Chain F: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain G: T.50, Q.474
- Ligands: IMP.23
12 PLIP interactions:11 interactions with chain F, 1 interactions with chain G- Hydrogen bonds: F:H.98, F:T.257, F:T.257, F:D.279, F:S.281, F:G.329, F:G.331, G:Q.474
- Salt bridges: F:H.258
- pi-Stacking: F:H.258, F:F.287, F:F.287
NAD.28: 15 residues within 4Å:- Chain G: T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain H: T.50, Q.474
- Ligands: IMP.27
13 PLIP interactions:11 interactions with chain G, 2 interactions with chain H- Hydrophobic interactions: G:Q.446
- Hydrogen bonds: G:H.98, G:T.257, G:T.257, G:D.279, G:S.281, G:G.329, G:G.331, H:Q.474, H:Q.474
- pi-Stacking: G:H.258, G:F.287, G:F.287
NAD.32: 17 residues within 4Å:- Chain E: T.50, Q.474
- Chain H: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, C.336, M.419, G.420, Q.446
- Ligands: IMP.31
13 PLIP interactions:12 interactions with chain H, 1 interactions with chain E- Hydrophobic interactions: H:Q.446
- Hydrogen bonds: H:T.257, H:T.257, H:D.279, H:S.281, H:S.281, H:G.329, H:G.331, E:Q.474
- Salt bridges: H:H.258
- pi-Stacking: H:H.258, H:F.287, H:F.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- O'Neill, A.G. et al., Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation. J.Biol.Chem. (2023)
- Release Date
- 2023-04-19
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- O'Neill, A.G. et al., Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation. J.Biol.Chem. (2023)
- Release Date
- 2023-04-19
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H